Genomic medicine is bringing hope where none previously existed. This approach to cure and treat human diseases uses human biology rather than chemical compounds made in the lab to unlock techniques and therapies with the power to cure formerly incurable diseases.
Read the postBioSpace recently spoke with Norman Sussman, chief medical officer at DURECT, a company committed to transforming the treatment of acute organ injury and chronic liver diseases.
Read the postBioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.
Read the postGene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 - an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the lab.
Read the postThe ability to consistently bring treatments and cures to market depends upon a company’s capacity to create and sustain a successful product development pipeline.
Read the postWritten for and originally published on AGT Big Picture Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing […]
Read the post